Articles related to CONTROLLED MEDICINES

A clinician educator outlines a framework for managing perceived “entitled” or demanding patient encounters by reframing behavior, applying motivational interviewing, and using perspective-based denial when setting limits.

Viatris recalled one lot of Xanax XR 3-mg extended-release tablets after failed dissolution testing, with the FDA classifying the action as Class II and reporting no adverse events to date.

Rather than referring patients with substance use disorder to treatment, the doctor prescribed an “astronomical amount of drugs” in dangerous combinations of addictive drugs to those patients.

Understanding the distinction between probable cause for arrest and evidence required for conviction is crucial for prescribers managing controlled substances.

Rapid symptom improvement and sustained 4-week benefits distinguish Spravato monotherapy in treatment-resistant depression, with significant MADRS score reductions versus placebo.

The expansion of this recall highlights the critical importance of verifying medication packaging against blister strip labeling, particularly for controlled substances where precise dosing is essential.